FindTrial
Sign In

Assessing the outcomes of using Brief Cognitive Therapy for Individuals with Suicidal thoughts and behaviours seeking psychiatric care.

Brief Cognitive Therapy for Individuals with Suicidal Risk Attending Psychiatric Services: A Preliminary Outcome Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/042090
Enrollment
50
Registered
2022-04-22
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F01-F99- Mental, Behavioral and Neurodevelopmental disorders

Interventions

Intervention1: Cognitive Therapy for Suicidal Patients (CT-SP): CT-SP is a cognitive-behavioural treatment for adults with suicidal ideation and behaviours (Wenzel et al., 2009). It is a manualized a

Sponsors

Swarnalakshmi S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Individuals with significant suicidal ideation or suicidal behaviours. A score of 3 or above on the suicide ideation severity subscale of the C-SSRS indicating active suicidal ideation in the past month and/or endorsement of any the suicidal behaviours ranging from preparatory acts to suicide attempts in the C-SSRS Suicidal Behaviour scale in the last 3 months will be considered as significant. - Individuals in the age range of 18 - 60 years. - Ability to read and write in English or Tamil.

Exclusion criteria

Exclusion criteria: - Individuals with diagnosis of schizophrenia, psychosis, bipolar affective disorder, severe depression or obsessive-compulsive disorder whose symptom severity prevents engagement in therapy based on clinical evaluation. - Clinical history suggestive of mental retardation and other developmental disorders including autism spectrum. - Underwent Electro-convulsive therapy (ECT) in the last 15 days.

Design outcomes

Primary

MeasureTime frame
Severity of suicidal ideation and behavioursTimepoint: 1. Baseline 2. Post-Treatment 3. 1-month follow-up 4. 3-months follow-up 5. 6 months follow-up—

Secondary

MeasureTime frame
Automatic thoughtsTimepoint: 1. Baseline 2. Post-Treatment 3. 3-months follow-up 4. 6 months follow-up;Cognitive control and flexibiltyTimepoint: 1. Baseline 2. Post-Treatment 3. 3-months follow-up 4. 6 months follow-up;Difficulties in emotion regulationTimepoint: 1. Baseline 2. Post-Treatment 3. 3-months follow-up 4. 6 months follow-up;General FunctioningTimepoint: 1. Baseline 2. Post-Treatment 3. 1-month follow-up 4. 3-months follow-up 5. 6 months follow-up;HopelessnessTimepoint: 1. Baseline 2. Post-Treatment 3. 3-months follow-up 4. 6 months follow-up;Problem solvingTimepoint: 1. Baseline 2. Post-Treatment 3. 3-months follow-up 4. 6 months follow-up;Severity of anxiety symptomsTimepoint: 1. Baseline 2. Post-Treatment 3. 3-months follow-up 4. 6 months follow-up;Severity of depressive symptomsTimepoint: 1. Baseline 2. Post-Treatment 3. 3-months follow-up 4. 6 months follow-up—

Countries

India

Contacts

Public ContactSwarnalakshmi S

National Institute of Mental Health and Neurosciences

drmanjula71@gmail.com08026995182

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026